Effect of the MDM2 antagonist RG7112 on the P53 pathway in patients with MDM2-amplified, well-differentiated or dedifferentiated liposarcoma: an exploratory proof-of-mechanism study

Nom du journal : Lancet Oncol

Année : 2012

Volume : 13

Page de départ : 1133

Page de fin : 1140

Auteurs: Ray-Coquard I, Blay JY, Italiano A, Le Cesne A, Penel N, Zhi J, Heil F, Rueger R, Graves B, Ding M, Geho D, Miiddleton SA, Vassilev LT, Nichols GL, Bui BN, Zhi J,